563 filings
Page 12 of 29
3
Truitt Joseph
5 Jun 20
Larimar Therapeutics / Joseph Truitt ownership change
7:41pm
3
Hamilton Thomas Edward
5 Jun 20
Larimar Therapeutics / Thomas Edward Hamilton ownership change
7:14pm
SC 13G/A
Hirschman Orin
5 Jun 20
Larimar Therapeutics / HIRSCHMAN ORIN ownership change
4:18pm
8-K
LRMR
Larimar Therapeutics Inc
3 Jun 20
Regulation FD Disclosure
12:00am
8-K
LRMR
Larimar Therapeutics Inc
2 Jun 20
Chondrial Therapeutics and Zafgen Complete Merger and Begin Operating as Larimar Therapeutics
7:49am
DEFA14A
LRMR
Larimar Therapeutics Inc
18 May 20
Additional proxy soliciting materials
9:55pm
10-Q
2020 Q1
LRMR
Larimar Therapeutics Inc
Quarterly report
7 May 20
4:38pm
UPLOAD
LRMR
Larimar Therapeutics Inc
30 Apr 20
Letter from SEC
12:00am
DEFM14A
LRMR
Larimar Therapeutics Inc
29 Apr 20
Proxy related to merger
3:20pm
PRER14A
LRMR
Larimar Therapeutics Inc
Preliminary revised proxy
27 Apr 20
9:30am
CORRESP
LRMR
Larimar Therapeutics Inc
27 Apr 20
Correspondence with SEC
12:00am
8-K
LRMR
Larimar Therapeutics Inc
24 Apr 20
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
5:01pm
UPLOAD
LRMR
Larimar Therapeutics Inc
24 Apr 20
Letter from SEC
12:00am
PRER14A
LRMR
Larimar Therapeutics Inc
10 Apr 20
Preliminary revised proxy
4:38pm
CORRESP
LRMR
Larimar Therapeutics Inc
10 Apr 20
Correspondence with SEC
12:00am
UPLOAD
LRMR
Larimar Therapeutics Inc
6 Apr 20
Letter from SEC
12:00am
DEFA14A
LRMR
Larimar Therapeutics Inc
9 Mar 20
Additional proxy soliciting materials
12:00am
8-K
LRMR
Larimar Therapeutics Inc
9 Mar 20
Entry into a Material Definitive Agreement
12:00am
PREM14A
LRMR
Larimar Therapeutics Inc
6 Mar 20
Preliminary proxy related to merger
5:32pm
S-8
LRMR
Larimar Therapeutics Inc
5 Mar 20
Registration of securities for employees
4:42pm